Potent Mitogenicity of the RET/PTC3 Oncogene Correlates with Its Prevalence in Tall-Cell Variant of Papillary Thyroid Carcinoma
Open Access
- 1 January 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 160 (1) , 247-254
- https://doi.org/10.1016/s0002-9440(10)64368-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Docking Protein FRS2 Links the Protein Tyrosine Kinase RET and Its Oncogenic Forms with the Mitogen-Activated Protein Kinase Signaling CascadeMolecular and Cellular Biology, 2001
- The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membraneOncogene, 2001
- Expression of DNA Topoisomerase IIα in Thyroid NeoplasiaLaboratory Investigation, 2000
- Molecular Basis of Hurthle Cell Papillary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2000
- Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant RasOncogene, 1999
- Pathomorphology of Thyroid Gland Lesions Associated with Radiation ExposureAdvances in Anatomic Pathology, 1999
- Concomitant activation of MEK-1 and Rac-1 increases the proliferative potential of thyroid epithelial cells, without affecting their differentiationOncogene, 1998
- Overexpression of p53 in tall cell variants of papillary thyroid carcinomaSurgery, 1996
- Tall Cell Variant of Papillary Thyroid CarcinomaThe American Journal of Surgical Pathology, 1996
- Cytogenetic findings in 31 papillary thyroid carcinomasGenes, Chromosomes and Cancer, 1995